Bordeaux, France (June 1, 2021) – FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, an Implantable Cardiac Output Management System designed to address the unmet need of
patients suffering from severe heart failure, today announced the successful completion of a €15 million funding round.
This enables FineHeart to prepare for First-In-Human clinical trials planned for 2022.
First In Human patients implanted successfully